29th week of 2020 patent applcation highlights part 23 |
Patent application number | Title | Published |
20200223831 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | 2020-07-16 |
20200223832 | Processes for the Preparation of Tezacaftor and Intermediates Thereof | 2020-07-16 |
20200223833 | NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF | 2020-07-16 |
20200223834 | GAMMA-DIKETONES AS WNT/BETA -CATENIN SIGNALING PATHWAY ACTIVATORS | 2020-07-16 |
20200223835 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | 2020-07-16 |
20200223836 | SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF | 2020-07-16 |
20200223837 | BENZOFURAN AMIDES AND HETEROAROMATIC ANALOGUES THEREOF FOR USE IN THERAPY | 2020-07-16 |
20200223838 | METHODS OF USE OF PHENOXYPROPYLAMINE COMPOUNDS TO TREAT DEPRESSION | 2020-07-16 |
20200223839 | FLUORO-CONTAINING COMPOUNDS, USE AND PREPARATION THEREOF | 2020-07-16 |
20200223840 | SUBSTITUTED PYRROLIDINE AMIDES III | 2020-07-16 |
20200223841 | NOVEL THERAPEUTIC AGENTS FOR THE TREATMENT OF HBV INFECTION | 2020-07-16 |
20200223842 | POTENT ANTIVIRAL PYRIDINE-CONTAINING COMPOUNDS | 2020-07-16 |
20200223843 | KINASE INHIBITORS | 2020-07-16 |
20200223844 | TRIAZOLOPYRIDIN-3-ONES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | 2020-07-16 |
20200223845 | NOVEL VIRAL REPLICATION INHIBITORS | 2020-07-16 |
20200223846 | 4,6,7-TRISUBSTITUTED 1,2-DIHYDROPYRROLO[3,4-C]PYRIDIN/PYRIMIDIN-3-ONE DERIVATIVES AND USES THEREOF | 2020-07-16 |
20200223847 | SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUNDS AND THE USES THEREOF | 2020-07-16 |
20200223848 | DEGRADATION AGENT USING AUTOPHAGIC MECHANISM OF DAMAGED MITOCHONDRIA | 2020-07-16 |
20200223849 | ADENINE DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT OF ALLERGIC DISEASES OR OTHER INFLAMMATORY CONDITIONS | 2020-07-16 |
20200223850 | PKC INHIBITOR SOLID STATE FORMS | 2020-07-16 |
20200223851 | COMPOSITIONS AND METHODS OF USING THE SAME FOR TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE | 2020-07-16 |
20200223852 | PROCESS FOR THE PREPARATION OF N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO[1,5-A][1- ,3,5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE | 2020-07-16 |
20200223853 | IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTION | 2020-07-16 |
20200223854 | BICYCLIC COMPOUNDS AS DUAL ATX/CA INHIBITORS | 2020-07-16 |
20200223855 | RSV ANTIVIRAL PYRAZOLO- AND TRIAZOLO-PYRIMIDINE COMPOUNDS | 2020-07-16 |
20200223856 | CRYSTALLINE FORMS OF A BRUTONS TYROSINE KINASE INHIBITOR | 2020-07-16 |
20200223857 | NITROGEN-CONTAINING FUSED HETEROCYCLIC RING COMPOUND AND APPLICATION THEREOF | 2020-07-16 |
20200223858 | DERIVATIVES OF PORPHYRINS, THEIR PROCESS OF PREPARATION AND THEIR USE FOR TREATING VIRAL INFECTIONS | 2020-07-16 |
20200223859 | REDUCTION OF ALPHA, BETA-UNSATURATED KETONE LEVELS IN MORPHINAN DERIVATIVE COMPOSITIONS | 2020-07-16 |
20200223860 | THE TOTAL SYNTHESIS OF GLUCOSEPANE AND RELATED CHEMICAL REACTIONS, COMPOUNDS AND COMPOSITIONS AND OBTAINED THEREFROM AND METHODS OF TREATMENT | 2020-07-16 |
20200223861 | Solid Forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)- pyrrole-2,5-dione | 2020-07-16 |
20200223862 | 4Beta-Amino Substituted Podophyllotoxin Derivative and Preparation Method Therefor and Use Thereof | 2020-07-16 |
20200223863 | SYNTHESIS OF HALICHONDRIN ANALOGS AND USES THEREOF | 2020-07-16 |
20200223864 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | 2020-07-16 |
20200223865 | MANUFACTURE OF 4,5,6,7-TETRAHYDROISOXAZOLO[5,4-C]PYRIDIN-3-OL | 2020-07-16 |
20200223866 | SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS | 2020-07-16 |
20200223867 | BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | 2020-07-16 |
20200223868 | CONDENSED HETEROCLYCLIC COMPOUNDS AND PESTICIDES | 2020-07-16 |
20200223869 | TERBIUM AND DYSPROSIUM COMPLEXES WITH OPTIMISED ANTENNA, USED AS LUMINESCENT MARKERS | 2020-07-16 |
20200223870 | PHOTOCHEMICAL METHODS OF MAKING CYCLOBUTANE BORONATES AND RELATED COMPOUNDS | 2020-07-16 |
20200223871 | Arginase Inhibitors and Methods of Use | 2020-07-16 |
20200223872 | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | 2020-07-16 |
20200223873 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | 2020-07-16 |
20200223874 | PROCESS FOR THE PRODUCTION OF ORGANOHYDRIDOCHLOROSILANES | 2020-07-16 |
20200223875 | TETRAZOLE SILANE COMPOUND, METHOD FOR SYNTHESIZING SAID COMPOUND AND USE THEREOF | 2020-07-16 |
20200223876 | BIOSENSOR | 2020-07-16 |
20200223877 | ORGANOMETALLIC COMPOUNDS AND PURIFICATION OF SUCH ORGANOMETALLIC COMPOUNDS | 2020-07-16 |
20200223878 | BIARYL LIGANDS, METHODS OF MAKING BIARLYL LIGANDS, AND METHODS OF USE THEREOF | 2020-07-16 |
20200223879 | PENTAAZA MACROCYCLIC RING COMPLEXES POSSESSING ORAL BIOAVAILABILITY | 2020-07-16 |
20200223880 | COBALT COMPLEXES, PROCESS FOR PREPARATION AND USE THEREOF | 2020-07-16 |
20200223881 | SYNTHESIS OF CYCLIC ORGANIC COMPOUNDS AND METALLOCENES | 2020-07-16 |
20200223882 | Ectonucleotidase Inhibitors and Methods of Use Thereof | 2020-07-16 |
20200223883 | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS | 2020-07-16 |
20200223884 | 3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF | 2020-07-16 |
20200223885 | FC-BINDING PROTEIN HAVING IMPROVED ANTIBODY SEPARATION ABILITY, AND METHOD FOR SEPARATING ANTIBODY USING SAME | 2020-07-16 |
20200223886 | Integrated Automated Filtration for Separation, Washing and Drying of Peptide Crystals | 2020-07-16 |
20200223887 | AROMATIC-CATIONIC PEPTIDES AND METHODS FOR USING SAME | 2020-07-16 |
20200223888 | DPEP-1 BINDING AGENTS AND METHODS OF USE | 2020-07-16 |
20200223889 | Bicyclic Compounds Capable of Binding to Melanocortin 4 Receptor | 2020-07-16 |
20200223890 | MACROCYCLIC POLYPEPTIDES | 2020-07-16 |
20200223891 | SCALABLE FERMENTATION PROCESS | 2020-07-16 |
20200223892 | ENGINEERED INFLUENZA ANTIGENIC POLYPEPTIDES AND IMMUNOGENIC COMPOSITIONS THEREOF | 2020-07-16 |
20200223893 | THERAPEUTIC NANOCONJUGATES AND USES THEREOF | 2020-07-16 |
20200223894 | PEPTIDES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH ADIPONECTIN DYSFUNCTION | 2020-07-16 |
20200223895 | THERAPEUTIC TARGETING OF SET1B/COMPASS PATHWAY FOR TREATING CANCERS | 2020-07-16 |
20200223896 | Long-acting Recombinant Porcine FSH Fusion Protein and Preparation Method and Application Thereof | 2020-07-16 |
20200223897 | GLUCAGON DERIVATIVE AND A COMPOSITION COMPRISING A LONG ACTING CONJUGATE OF THE SAME | 2020-07-16 |
20200223898 | Fully-human T-cell receptor specific for the 369-377 epitope derived from the Her2/Neu (ERBB2) receptor protein. | 2020-07-16 |
20200223899 | BRAF-SPECIFIC TCRS AND USES THEREOF | 2020-07-16 |
20200223900 | PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS | 2020-07-16 |
20200223901 | IMMUNOMODULATORY FUSION PROTEINS | 2020-07-16 |
20200223902 | PROCESS FOR PREPARING APOLIPOPROTEIN A-I (APO A-I) | 2020-07-16 |
20200223903 | Peptides Derived from Fibronectin with Improved Bioactivity and Reduced Susceptibility to Neutrophil Elastase Degradation | 2020-07-16 |
20200223904 | CANINE ANTIBODY LIBRARIES | 2020-07-16 |
20200223905 | Anti-Influenza B Virus Neuraminidase Antibodies And Uses Thereof | 2020-07-16 |
20200223906 | ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE | 2020-07-16 |
20200223907 | ANTIBODIES THAT TARGET HIV GP120 AND METHODS OF USE | 2020-07-16 |
20200223908 | METHOD FOR TREATING INFECTIOUS DISEASES USING A COMPOSITION COMPRISING PLASMA-DERIVED IMMUNOGLOBULIN M (IgM) | 2020-07-16 |
20200223909 | Fungal Detection Using Mannan Epitope | 2020-07-16 |
20200223910 | HUMAN ANTIBODIES AND BINDING FRAGMENTS THEREOF TO TENASCIN | 2020-07-16 |
20200223911 | TREATING REFRACTORY MIGRAINE | 2020-07-16 |
20200223912 | HUMANIZED ANTI-TAU(PS422) ANTIBODIES AND METHODS OF USE | 2020-07-16 |
20200223913 | ANTIBODY PURIFICATION AND PURITY MONITORING | 2020-07-16 |
20200223914 | USE OF ANTI-FAM19A5 ANTIBODIES FOR TREATING CANCERS | 2020-07-16 |
20200223915 | Claudin 5 ANTIBODY, AND MEDICINE CONTAINING SAID ANTIBODY | 2020-07-16 |
20200223916 | HUMANIZED ANTIBODY FOR TREATING OR PREVENTING COGNITIVE DISORDERS, PROCESS FOR PRODUCING THE SAME, AND AGENT FOR TREATING OR PREVENTING COGNITIVE DISORDERS USING THE SAME | 2020-07-16 |
20200223917 | ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF | 2020-07-16 |
20200223918 | CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF | 2020-07-16 |
20200223919 | ANTI-CD166 ANTIBODIES AND USES THEREOF | 2020-07-16 |
20200223920 | COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS | 2020-07-16 |
20200223921 | TREATING CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND | 2020-07-16 |
20200223922 | MARKERS OF ACUTE MYELOID LEUKEMIA STEM CELLS | 2020-07-16 |
20200223923 | ENHANCED DEPLETION OF TARGETED CELLS WITH CD47 BLOCKADE AND AN IMMUNE COSTIMULATORY AGONIST | 2020-07-16 |
20200223924 | DOSAGE REGIMENS FOR ANTI-TIM-3 ANTIBODIES AND USES THEREOF | 2020-07-16 |
20200223925 | TUMOR-TARGETED SUPERAGONISTIC CD28 ANTIGEN BINDING MOLECULES | 2020-07-16 |
20200223926 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS | 2020-07-16 |
20200223927 | METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS | 2020-07-16 |
20200223928 | ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOF | 2020-07-16 |
20200223929 | ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) ANTIBODIES | 2020-07-16 |
20200223930 | RECOMBINANT CD123-BINDING ANTIBODIES | 2020-07-16 |